• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症重复进行符号数字模式测验时的练习效应平台期及噪声

Plateau of practice effects and noise with repeat SDMT testing in multiple sclerosis.

作者信息

Novakova Lenka, Rosenstein Igal, Axelsson Markus, Schoonheim Menno M, Benedict Ralph Hb, Fuchs Tom A

机构信息

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Region Västra Götaland, Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

Mult Scler. 2025 Aug;31(9):1121-1129. doi: 10.1177/13524585251344794. Epub 2025 May 31.

DOI:10.1177/13524585251344794
PMID:40448412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12357967/
Abstract

BACKGROUND

The Symbol Digit Modalities Test (SDMT) is the most widely used test of cognition in people with multiple sclerosis (PwMS), and repeated testing is confounded by test-retest noise and practice effects.

OBJECTIVE

To investigate the extent to which SDMT practice effects build and plateau with high-frequency testing, reliable cutoffs for longitudinal change, and whether short-interval testing improves detection of cognitive decline.

METHODS

PwMS were tested with the SDMT monthly across 3 years. Plateau regression analyses were used to determine inflection points of practice effects, and the reliable-change was assessed. To evaluate effects of testing density on cognitive decline detection, this sample was compared with a separate low-density testing group.

RESULTS

The study included 71 people with relapsing-remitting MS (77.5% female), mean (standard deviation (SD)) age 37.3 (9.3), with 27.8 (21.3) SDMT assessments over 3.2 (2.4) years. The plateau of practice effects was reached after 18 repetitions ( < 0.001). Within this sample, ⩾7-point SDMT change was needed to detect cognitive decline with 90% confidence. Higher testing density did not improve detection of cognitive decline ( = 0.256).

CONCLUSION

We observed practice effects building for eighteen SDMT assessments and test-retest variability consistent with literature. These results provide guidance on SDMT which should be accounted for with alternate versions and reliable-change methodologies.

摘要

背景

符号数字模式测验(SDMT)是多发性硬化症患者(PwMS)中使用最广泛的认知测试,重复测试会受到重测噪声和练习效应的干扰。

目的

研究SDMT练习效应在高频测试中形成和稳定的程度、纵向变化的可靠临界值,以及短间隔测试是否能改善对认知衰退的检测。

方法

PwMS在3年时间里每月进行一次SDMT测试。采用平台期回归分析来确定练习效应的拐点,并评估可靠变化。为了评估测试密度对认知衰退检测的影响,将该样本与另一个低密度测试组进行比较。

结果

该研究纳入了71例复发缓解型多发性硬化症患者(77.5%为女性),平均(标准差)年龄37.3(9.3)岁,在3.2(2.4)年中进行了27.8(21.3)次SDMT评估。18次重复后达到练习效应的平台期(<0.001)。在这个样本中,需要SDMT变化≥7分才能以90%的置信度检测到认知衰退。更高的测试密度并没有改善对认知衰退的检测(=0.256)。

结论

我们观察到SDMT评估进行18次时会产生练习效应,且重测变异性与文献一致。这些结果为SDMT提供了指导,应通过替代版本和可靠变化方法加以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fed/12357967/084bc900de54/10.1177_13524585251344794-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fed/12357967/74f9ff7a7d3a/10.1177_13524585251344794-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fed/12357967/084bc900de54/10.1177_13524585251344794-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fed/12357967/74f9ff7a7d3a/10.1177_13524585251344794-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fed/12357967/084bc900de54/10.1177_13524585251344794-fig2.jpg

相似文献

1
Plateau of practice effects and noise with repeat SDMT testing in multiple sclerosis.多发性硬化症重复进行符号数字模式测验时的练习效应平台期及噪声
Mult Scler. 2025 Aug;31(9):1121-1129. doi: 10.1177/13524585251344794. Epub 2025 May 31.
2
Learning as a digital hallmark of cognition in multiple sclerosis: lessons from a digital symbol digit modalities test.学习作为多发性硬化症认知的数字标志:来自数字符号数字模态测试的经验教训。
J Neurol. 2025 Jul 25;272(8):536. doi: 10.1007/s00415-025-13270-2.
3
Azathioprine for people with multiple sclerosis.硫唑嘌呤用于多发性硬化症患者。
Cochrane Database Syst Rev. 2024 Dec 9;12(12):CD015005. doi: 10.1002/14651858.CD015005.pub2.
4
Smartphone monitoring of cognition in people with multiple sclerosis: A systematic review.智能手机监测多发性硬化症患者认知功能:系统评价。
Mult Scler Relat Disord. 2023 May;73:104674. doi: 10.1016/j.msard.2023.104674. Epub 2023 Mar 27.
5
Serum lipids and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis.血清脂质与多发性硬化症的认知结果:系统评价和荟萃分析。
Mult Scler Relat Disord. 2024 May;85:105530. doi: 10.1016/j.msard.2024.105530. Epub 2024 Feb 29.
6
Instruments measuring change in cognitive function in multiple sclerosis: A systematic review.用于多发性硬化症认知功能改变的测量仪器:系统评价。
Brain Behav. 2023 Jun;13(6):e3009. doi: 10.1002/brb3.3009. Epub 2023 Apr 16.
7
Cholinesterase inhibitors for rarer dementias associated with neurological conditions.用于治疗与神经疾病相关的罕见痴呆症的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2015 Mar 3;2015(3):CD009444. doi: 10.1002/14651858.CD009444.pub3.
8
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis.丘脑萎缩和连接障碍与复发缓解型多发性硬化患者多中心临床常规真实世界研究中的认知障碍相关。
Neuroimage Clin. 2024;42:103609. doi: 10.1016/j.nicl.2024.103609. Epub 2024 Apr 27.
9
Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational Study.基于芬兰登记处的多发性硬化症疲劳和认知问题筛查与管理方案:观察性研究
JMIR Hum Factors. 2025 Aug 22;12:e67990. doi: 10.2196/67990.
10
Cognitive changes in patients with relapse-free MS treated with high efficacy therapies: the predictive value of paramagnetic rim lesions.接受高效疗法治疗的无复发多发性硬化症患者的认知变化:顺磁性边缘病变的预测价值
J Neurol Neurosurg Psychiatry. 2025 Jul 16;96(8):807-813. doi: 10.1136/jnnp-2024-335144.

本文引用的文献

1
Meaningful cognitive change for the Minimal Assessment of Cognitive Function in Multiple Sclerosis.多发性硬化症中认知功能最小评估的有意义认知变化。
Mult Scler. 2024 Jun;30(7):868-876. doi: 10.1177/13524585241249084. Epub 2024 May 8.
2
Evaluation of a self-administered iPad-based processing speed assessment for people with multiple sclerosis in a clinical routine setting.在临床常规环境中评估基于 iPad 的自我管理处理速度评估对多发性硬化症患者的影响。
J Neurol. 2024 Jun;271(6):3268-3278. doi: 10.1007/s00415-024-12274-8. Epub 2024 Mar 5.
3
Don't be late! Timely identification of cognitive impairment in people with multiple sclerosis: a study protocol.
切勿延误!对多发性硬化症患者认知障碍的及时识别:一项研究方案。
BMC Neurol. 2024 Jan 13;24(1):26. doi: 10.1186/s12883-023-03495-x.
4
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic Review.统一多发性硬化症中与复发活动无关的进展的定义:一项系统评价
JAMA Neurol. 2023 Nov 1;80(11):1232-1245. doi: 10.1001/jamaneurol.2023.3331.
5
Detecting isolated cognitive relapses in persons with MS.检测多发性硬化症患者的孤立性认知发作。
Mult Scler. 2023 Dec;29(14):1786-1794. doi: 10.1177/13524585231201219. Epub 2023 Sep 30.
6
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.首发多发性硬化症疾病调节治疗后 11 年内认知处理速度和身体残疾的轨迹。
J Neurol Neurosurg Psychiatry. 2024 Jan 11;95(2):134-141. doi: 10.1136/jnnp-2023-331784.
7
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).验证多发性硬化症的简短国际认知评估的 iPad 版本(BICAMS)。
Mult Scler Relat Disord. 2023 Jun;74:104723. doi: 10.1016/j.msard.2023.104723. Epub 2023 Apr 17.
8
Longitudinal Changes in Cognitive Test Scores in Patients With Relapsing-Remitting Multiple Sclerosis: An Analysis of the DECIDE Dataset.复发缓解型多发性硬化症患者认知测试评分的纵向变化:DECIDE 数据集分析。
Neurology. 2023 Jul 4;101(1):e1-e11. doi: 10.1212/WNL.0000000000207301. Epub 2023 Apr 18.
9
Smartphone monitoring of cognition in people with multiple sclerosis: A systematic review.智能手机监测多发性硬化症患者认知功能:系统评价。
Mult Scler Relat Disord. 2023 May;73:104674. doi: 10.1016/j.msard.2023.104674. Epub 2023 Mar 27.
10
Assessment of cognitive performance in multiple sclerosis using smartphone-based training games: a feasibility study.使用基于智能手机的训练游戏评估多发性硬化症患者的认知表现:一项可行性研究。
J Neurol. 2023 Jul;270(7):3451-3463. doi: 10.1007/s00415-023-11671-9. Epub 2023 Mar 23.